Cargando…

Primary Neuroendocrine Tumor of the Scrotum: An Uncommon Site for a Rare Tumor

Neuroendocrine tumors (NETs) are a heterogeneous group of tumors developing from neural crest cells, with numerous sites of origin, commonly the gastrointestinal and genitourinary tracts. NETs of the genitourinary tract are more common in women. Small cell carcinoma of the prostate or testicular car...

Descripción completa

Detalles Bibliográficos
Autores principales: Akhtar, Komal, Vyas, Vrinda, Ashok Kumar, Prashanth, Corines, James, de la Roza, Gustavo, Basnet, Alina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040611/
https://www.ncbi.nlm.nih.gov/pubmed/33834875
http://dx.doi.org/10.1177/23247096211008717
_version_ 1783677818466467840
author Akhtar, Komal
Vyas, Vrinda
Ashok Kumar, Prashanth
Corines, James
de la Roza, Gustavo
Basnet, Alina
author_facet Akhtar, Komal
Vyas, Vrinda
Ashok Kumar, Prashanth
Corines, James
de la Roza, Gustavo
Basnet, Alina
author_sort Akhtar, Komal
collection PubMed
description Neuroendocrine tumors (NETs) are a heterogeneous group of tumors developing from neural crest cells, with numerous sites of origin, commonly the gastrointestinal and genitourinary tracts. NETs of the genitourinary tract are more common in women. Small cell carcinoma of the prostate or testicular carcinoid are the NETs in male. In this article, we present a rare case of NET of the scrotum. Our patient was a 47-year-old male with a history of complicated pilonidal cysts resulting in chronic scrotal wounds. Biopsy of a large nonhealing scrotal wound revealed a high-grade neuroendocrine carcinoma with features most suggestive of small cell carcinoma. Presenting with advanced disease at diagnosis, he was started on systemic therapy and unfortunately progressed through multiple lines of treatment, including CAPTEM (capecitabine and temozolomide). Unfortunately, due to multiple logistical reasons, the patient was unable to receive the then off-label immunotherapy based on DART (Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors) trial. He, unfortunately, succumbed to his disease within months of diagnosis.
format Online
Article
Text
id pubmed-8040611
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-80406112021-04-21 Primary Neuroendocrine Tumor of the Scrotum: An Uncommon Site for a Rare Tumor Akhtar, Komal Vyas, Vrinda Ashok Kumar, Prashanth Corines, James de la Roza, Gustavo Basnet, Alina J Investig Med High Impact Case Rep Case Report Neuroendocrine tumors (NETs) are a heterogeneous group of tumors developing from neural crest cells, with numerous sites of origin, commonly the gastrointestinal and genitourinary tracts. NETs of the genitourinary tract are more common in women. Small cell carcinoma of the prostate or testicular carcinoid are the NETs in male. In this article, we present a rare case of NET of the scrotum. Our patient was a 47-year-old male with a history of complicated pilonidal cysts resulting in chronic scrotal wounds. Biopsy of a large nonhealing scrotal wound revealed a high-grade neuroendocrine carcinoma with features most suggestive of small cell carcinoma. Presenting with advanced disease at diagnosis, he was started on systemic therapy and unfortunately progressed through multiple lines of treatment, including CAPTEM (capecitabine and temozolomide). Unfortunately, due to multiple logistical reasons, the patient was unable to receive the then off-label immunotherapy based on DART (Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors) trial. He, unfortunately, succumbed to his disease within months of diagnosis. SAGE Publications 2021-04-09 /pmc/articles/PMC8040611/ /pubmed/33834875 http://dx.doi.org/10.1177/23247096211008717 Text en © 2021 American Federation for Medical Research https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Report
Akhtar, Komal
Vyas, Vrinda
Ashok Kumar, Prashanth
Corines, James
de la Roza, Gustavo
Basnet, Alina
Primary Neuroendocrine Tumor of the Scrotum: An Uncommon Site for a Rare Tumor
title Primary Neuroendocrine Tumor of the Scrotum: An Uncommon Site for a Rare Tumor
title_full Primary Neuroendocrine Tumor of the Scrotum: An Uncommon Site for a Rare Tumor
title_fullStr Primary Neuroendocrine Tumor of the Scrotum: An Uncommon Site for a Rare Tumor
title_full_unstemmed Primary Neuroendocrine Tumor of the Scrotum: An Uncommon Site for a Rare Tumor
title_short Primary Neuroendocrine Tumor of the Scrotum: An Uncommon Site for a Rare Tumor
title_sort primary neuroendocrine tumor of the scrotum: an uncommon site for a rare tumor
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040611/
https://www.ncbi.nlm.nih.gov/pubmed/33834875
http://dx.doi.org/10.1177/23247096211008717
work_keys_str_mv AT akhtarkomal primaryneuroendocrinetumorofthescrotumanuncommonsiteforararetumor
AT vyasvrinda primaryneuroendocrinetumorofthescrotumanuncommonsiteforararetumor
AT ashokkumarprashanth primaryneuroendocrinetumorofthescrotumanuncommonsiteforararetumor
AT corinesjames primaryneuroendocrinetumorofthescrotumanuncommonsiteforararetumor
AT delarozagustavo primaryneuroendocrinetumorofthescrotumanuncommonsiteforararetumor
AT basnetalina primaryneuroendocrinetumorofthescrotumanuncommonsiteforararetumor